177 related articles for article (PubMed ID: 15328108)
21. Multidrug-resistant Escherichia coli clonal groups causing community-acquired pyelonephritis.
Manges AR; Dietrich PS; Riley LW
Clin Infect Dis; 2004 Feb; 38(3):329-34. PubMed ID: 14727201
[TBL] [Abstract][Full Text] [Related]
22. Trimethoprim in vitro antibacterial activity is not increased by adding sulfamethoxazole for pediatric Escherichia coli urinary tract infection.
Nguyen HT; Hurwitz RS; Defoor WR; Minevich E; McAdam AJ; Mortensen JE; Novak-Weekley SM; Minnillo BJ; Elder JS
J Urol; 2010 Jul; 184(1):305-10. PubMed ID: 20488468
[TBL] [Abstract][Full Text] [Related]
23. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
Ejrnæs K
Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
[TBL] [Abstract][Full Text] [Related]
24. Infections during induction therapy for children with acute lymphoblastic leukemia. the role of sulfamethoxazole-trimethoprim (SMX-TMP) prophylaxis.
Rungoe C; Malchau EL; Larsen LN; Schroeder H
Pediatr Blood Cancer; 2010 Aug; 55(2):304-8. PubMed ID: 20583218
[TBL] [Abstract][Full Text] [Related]
25. Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era.
Martin JN; Rose DA; Hadley WK; Perdreau-Remington F; Lam PK; Gerberding JL
J Infect Dis; 1999 Dec; 180(6):1809-18. PubMed ID: 10558935
[TBL] [Abstract][Full Text] [Related]
26. A comparison of trimethorprim-sulfamethoxazole with sulfamethoxazole alone in infections localized to the kidneys.
Harding GK; Ronald AR; Boutros P; Lank B
Can Med Assoc J; 1975 Jun; 112(13 Spec No):9-12. PubMed ID: 1093658
[TBL] [Abstract][Full Text] [Related]
27. In vivo bioluminescence imaging.
Sato A; Klaunberg B; Tolwani R
Comp Med; 2004 Dec; 54(6):631-4. PubMed ID: 15679260
[TBL] [Abstract][Full Text] [Related]
28. Trimethoprim-resistant Enterobacteriaceae in urinary tract infection.
Wong CK; Harding GK; Ronald AR; Hoban S
Can Med Assoc J; 1975 Jun; 112(13 Spec No):54-8. PubMed ID: 1093652
[TBL] [Abstract][Full Text] [Related]
29. Role of rifampicin in limiting Escherichia coli O157:H7 Shiga-like toxin expression and enhancement of survival of infected BALB/c mice.
Rahal EA; Kazzi N; Kanbar A; Abdelnoor AM; Matar GM
Int J Antimicrob Agents; 2011 Feb; 37(2):135-9. PubMed ID: 21129928
[TBL] [Abstract][Full Text] [Related]
30. Trimethoprim/sulfamethoxazole resistance in urinary tract infections.
Guneysel O; Onur O; Erdede M; Denizbasi A
J Emerg Med; 2009 May; 36(4):338-41. PubMed ID: 18325714
[TBL] [Abstract][Full Text] [Related]
31. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
[TBL] [Abstract][Full Text] [Related]
32. Trimethoprim/sulfametrole: evaluation of the available clinical and pharmacokinetic/pharmacodynamic evidence.
Vouloumanou EK; Karageorgopoulos DE; Rafailidis PI; Michalopoulos A; Falagas ME
Int J Antimicrob Agents; 2011 Sep; 38(3):197-216. PubMed ID: 21741802
[TBL] [Abstract][Full Text] [Related]
33. Antibiotic combinations significantly more active than monotherapy in an in vitro infection model of Stenotrophomonas maltophilia.
Zelenitsky SA; Iacovides H; Ariano RE; Harding GK
Diagn Microbiol Infect Dis; 2005 Jan; 51(1):39-43. PubMed ID: 15629227
[TBL] [Abstract][Full Text] [Related]
34. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
Yamane K; Wachino J; Suzuki S; Kimura K; Shibata N; Kato H; Shibayama K; Konda T; Arakawa Y
Antimicrob Agents Chemother; 2007 Sep; 51(9):3354-60. PubMed ID: 17548499
[TBL] [Abstract][Full Text] [Related]
35. A survey of plasmid-mediated fluoroquinolone resistance genes from Escherichia coli isolates and their dissemination in Shandong, China.
Xia LN; Li L; Wu CM; Liu YQ; Tao XQ; Dai L; Qi YH; Lu LM; Shen JZ
Foodborne Pathog Dis; 2010 Feb; 7(2):207-15. PubMed ID: 19911944
[TBL] [Abstract][Full Text] [Related]
36. Phenotypic and genotypic characterisation of thymine auxotrophy in Escherichia coli isolated from a patient with recurrent bloodstream infection.
Jakovljev A; Afset JE; Haugum K; Steinum HO; Gresdal Rønning T; Samuelsen Ø; Ås CG
PLoS One; 2022; 17(7):e0270256. PubMed ID: 35802671
[TBL] [Abstract][Full Text] [Related]
37. Relationship between phenotypic and genotypic florfenicol resistance in Escherichia coli.
Singer RS; Patterson SK; Meier AE; Gibson JK; Lee HL; Maddox CW
Antimicrob Agents Chemother; 2004 Oct; 48(10):4047-9. PubMed ID: 15388477
[TBL] [Abstract][Full Text] [Related]
38. Influence of Antibiotic Pressure on Five Plasmid-based Bioluminescent Gram-negative Bacterial Strains.
Wang X; Chi H; Li Q; Li W; Li J; Li B; Gao W; Zhang D; Sun Y; Yi L; Qu H; Wang Y; Li Z; Xia Z
Mol Imaging Biol; 2018 Feb; 20(1):21-26. PubMed ID: 28791565
[TBL] [Abstract][Full Text] [Related]
39. Deletion of
Li K; Li T; Yang SS; Wang XD; Gao LX; Wang RQ; Gu J; Zhang XE; Deng JY
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223385
[TBL] [Abstract][Full Text] [Related]
40. Estimation of the bacteriocin ColE7 conjugation-based "kill" - "anti-kill" antimicrobial system by real-time PCR, fluorescence staining and bioluminescence assays.
Maslennikova IL; Kuznetsova MV; Toplak N; Nekrasova IV; Žgur Bertok D; Starčič Erjavec M
Lett Appl Microbiol; 2018 Jul; 67(1):47-53. PubMed ID: 29736984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
